Fact.MR, a market research and competitive intelligence provider: The global regulatory affairs outsourcing market is anticipated to secure a market value of US$ 15.11 Bn by 2032 while expanding at a CAGR of 8% during the forecast period from 2022 to 2032.
Rapid Growth Of The Pharmaceutical And Biotechnology Sectors Is Likely To Offer Significant Growth Opportunities To The Regulatory Affairs Outsourcing Market.
Fact.MR, a market research and competitive intelligence provider: The global regulatory affairs outsourcing market is anticipated to secure a market value of US$ 15.11 Bn by 2032 while expanding at a CAGR of 8% during the forecast period from 2022 to 2032. The rising number of product registrations and the growing clinical trial applications are key factors propelling the market growth.
In addition, the rapid development of the biotechnology and pharmaceutical industry is projected to hold significant opportunities for market expansion in the forthcoming period. The rising demand to reduce costs in the life-sciences industry is enhancing the demand for third-party services for regulatory affairs.
The growing pressure on personal pockets and the initiatives taken by various governments in the concerned field are likely to provide thrust to the industry’s growth. Also, the growing demand to reduce costs in the life-science sector is likely to create a significant demand for third-party services for regulatory affairs. In addition, the increasing application of efficacious software to keep a record of regulatory affairs is expected to augment the market size during the forecast period.
For more insights into the Market, Get A Sample of this Report!
https://www.factmr.com/connectus/sample?flag=S&rep_id=7143
The outbreak of the COVID-19 pandemic posed a major challenge across the globe which resulted in emergency usage of various equipment approved by FDA and EU, which boosted the market significantly during the lockdown period. Moreover, development of critical vaccines and drugs to counter the coronavirus threat has further widened prospects for the market.
Key Takeaways from the Market Study
- The global regulatory affairs outsourcing market to value US$ 7 Bn in 2022
- From 2015-2021, regulatory affairs outsourcing demand flourished at a 6.5% CAGR
- APAC to garner a market share of 37% in 2022 with respect to regulatory affairs outsourcing
- Clinical studies segment procured the largest market share of 46% in 2021.
- Based on end-user segment, the pharmaceutical companies segment to secure the largest market share of 38% in 2022.
“The advent of smart technology in the healthcare sector is likely to transform the sector in the coming time, benefitting the market considerably. “- says an analyst at Fact. MR.
Competitive Landscape
The players of the global regulatory affairs outsourcing market focus on expanding their global influence. Some of the adopted strategies are partnerships, collaborations, and acquisitions. Recent key developments among key players are:
- In August 2021, ProPharma Group, a portfolio company of Odyssey Investment Partners, announced the acquisition of iSafety Systems. iSafety is an Indian pharmacovigilance outsourcing service provider.
- In July 2021, ICON plc acquired a CRO, called PRA Health Sciences. The objective of the acquisition was to increase the services portfolio of ICON plc. The company plans to continue its original name, ICON. It aims to bring together 38,000 employees across 47 countries and create the most developed clinical research organization and healthcare intelligence.
For Comprehensive Insights Ask An Analyst Here https://www.factmr.com/connectus/sample?flag=AE&rep_id=7143 Key Market Segments Covered in the Global Regulatory Affairs Outsourcing Market
- By Services
- Regulatory Consulting Outsourcing
- Legal Representation Outsourcing
- Regulatory Writing & Publishing Outsourcing
- Other Regulatory Affairs Outsourcing Services
- By Company Size
- Regulatory Affairs Outsourcing for Small Sized Companies
- Regulatory Affairs Outsourcing for Medium Sized Companies
- Regulatory Affairs Outsourcing for Large Sized Companies
- By Category
- Regulatory Affairs Outsourcing for Drugs
- Generics
- Innovators
- Regulatory Affairs Outsourcing for Biologics
- Biotech
- ATMPs
- Biosimilars
- Regulatory Affairs Outsourcing for Medical Devices
- Therapeutic
- Diagnostic
- Regulatory Affairs Outsourcing for Drugs
- By Indication
- Regulatory Affairs Outsourcing for Oncology
- Regulatory Affairs Outsourcing for Neurology
- Regulatory Affairs Outsourcing for Radiology
- Regulatory Affairs Outsourcing for Immunology
- Regulatory Affairs Outsourcing for Other Indications
- By Stage
- Pre-Clinical Regulatory Affairs Outsourcing
- Clinical Regulatory Affairs Outsourcing
- Post Market Authorization Regulatory Affairs Outsourcing
- By End Use
- Regulatory Affairs Outsourcing for Medical Device Companies
- Regulatory Affairs Outsourcing for Pharmaceutical Companies
- Regulatory Affairs Outsourcing for Biotechnology Companies
More Valuable Insights
Fact.MR, in its new offering, presents an unbiased analysis of the global regulatory affairs outsourcing market, presenting historical market data (2015-2021) and forecast statistics for the period of 2022-2032.
The study reveals essential insights based on services (product registration & clinical trial applications, legal representation, regulatory consulting, regulatory writing & publishing and other services), category (biologics, drugs and medical devices), company size (small sized companies, medium sized companies and large sized companies), indication (immunology, neurology, cardiology, oncology and others), stage (pre-clinical, clinical and PMA (post market authorization)) and end use (medical device companies, pharmaceutical companies and biotechnology companies) across five major regions (North America, MEA, Latin America, Europe and Asia Pacific).
Get Customization on this Report for Specific Research Solutions
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7143
About Healthcare Division at Fact.MR
Expert analysis, actionable insights, and strategic recommendations of the highly seasoned healthcare team at Fact.MR helps clients from across the globe with their unique business intelligence needs. With a repertoire of over thousand reports and 1 million-plus data points, the team has analyzed the healthcare industry across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services.
Check out more studies related to Healthcare Industry, conducted by Fact.MR:
Transcatheter Valve Replacement Market - Transcatheter Valve Replacement Market Analysis, By Replacement Type (Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Repair (TMVR)), By Surgical Approach (Trans-femoral Approach, Trans-apical Approach, Trans-aortic Approach), By End User (Hospitals, Ambulatory Surgical Centres, Specialty Clinics) - Global Market Insights 2022 to 2032
Collateral Ligament Stabilizer System Market - Collateral Ligament Stabilizer System Market Analysis by Ligament (Medial collateral Ligament (MCL), Lateral Collateral Ligament (LCL)) by Injury type (Grade 1, Grade 2, Grade 3), by End Use (Hospitals, orthopedic clinics, others) and Region Forecast- 2022-2032
Contrast Media Injectors Market - Contrast Media Injectors Market by Product (Consumables, Injector Systems, Accessories), Application (Radiology, Interventional Radiology, Interventional Cardiology), End-User (Hospitals, Diagnostic Imaging Centers), & Regional Analysis till 2032
Medical Nonwoven Disposables Market - Medical Nonwoven Disposables Market Analysis by Product Type (Incontinence Hygiene Products, Sterile Nonwoven Products, and Wound Dressing), by Material (Polypropylene, Polyethylene, Acetate, Rayon, Polyamides & Polyesters, Acrylic, and Others), by End User (Hospitals, Nursing Homes, Home Healthcare, Ambulatory Centres, and Others), and by Region – Forecast to 2022-2032
Idiopathic Thrombocytopenic Purpura Therapeutics Market - Idiopathic Thrombocytopenic Purpura Therapeutics Market Analysis by Product Type (Corticosteroids, Intravenous Immunoglobulins, Anti-D Immunoglobulin, Thrombopoietin Receptor Agonists (TPO-RA), and Others), By Distribution Channel Type (Drug Store, Retail Pharmacies, and Others), By Treatment Type (Oral Corticosteroids, and Splenectomy) and Region Forecast- 2022-2032
Mixed Mode Chromatography Resin Market - Mixed Mode Chromatography Resin Market Analysis by Type (Ion Exchange Hydrophobic Type, Hydroxyapatite Type, and Others), by Application (Antibodies Production, Vaccine Production, Non-antibody Proteins, Antibody-drug Conjugate, Separation of Low Molecular Weight Impurities, and others), and by Region (North America, Latin America, Europe, Asia Pacific, and Middle East and Africa) – Forecast to 2022-2032
Mobile Imaging Services Market - Mobile Imaging Services Market Analysis By Product Type (X-Ray, CT, Ultrasound, MRI, Mammography, Nuclear Imaging, Others), End User (Hospitals & Private Clinics, Home Healthcare, Others), & Region Forecast till 2032
Europe Patient Positioning System Market - Europe Patient Positioning System Market Analysis, By Product (Patient Positioning Tables, Surgical Tables, Radiolucent Imaging Tables, Examination Tables, Patient Positioning Accessories), By Application (Surgeries, Disease Diagnosis & Imaging, Cancer Therapy), By End User (Hospitals, Ambulatory Surgical Centres, Diagnostic Centres) - European Market Insights 2022 to 2032
U.S. Patient Positioning System Market - U.S. Patient Positioning System Market Analysis, By Product (Patient Positioning Tables, Surgical Tables, Radiolucent Imaging Tables, Examination Tables, Patient Positioning Accessories), By Application (Surgeries, Disease Diagnosis & Imaging, Cancer Therapy), By End User (Hospitals, Ambulatory Surgical Centres, Diagnostic Centres) – United States Market Insights 2022 to 2032
Intrapartum Monitoring Devices Market - Intrapartum Monitoring Devices Market Analysis by Product (Monitors, Electrodes) and Region Forecast- 2022-2032
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email: sales@factmr.com
Tel: +1 (628) 251-158